Real estate investment firm and developer DivcoWest has announced the topping off of a 480,000-square-foot life sciences property at the 43-acre Cambridge Crossing mixed-use neighborhood at the intersection of the cities of Boston, Cambridge and Somerville.
Located at 250 Water St., biopharmaceutical firm Bristol Myers Squibb has preleased 360,000 square feet at the building, which is slated to be completed in the first quarter of 2022.
Cambridge Crossing is slated to consist of 2 million square feet of laboratory and office space, 2.4 million square feet of residential space and 100,000 square feet of retail space. The project is connected to two stops on the MBTA Green Line. Additional life sciences users at Cambridge Crossing are planned to include Sanofi and Cerevel Therapeutics.
David Cohen is Southeast Editorial Director at Connect Commercial Real Estate. David is a media veteran with more than 10 years of experience in journalism, copywriting and communications across a variety of roles.
Email the Author
Reach over 250,000 Commercial Real Estate Professionals with Connect
Connect CRE reaches the top commercial real estate players nationwide and across all property types, offering you a variety of ways to showcase your team, your expertise and your brand to CRE decision makers.
The home for CRE news and everything you need to stay informed on deals, trends, and transactions, providing a platform to get your brand in front of your target audience.
Daily CRE Emails
Reaching over 150,000 inboxes across the nation every day, Connect’s Daily News emails provide advertising opportunities specific to your market.
Bi-Weekly Property Sector Emails
Focus your advertising on emails dedicated to your property sector and stay visible to current and potential clients.
Position your team as experts in your field with content created by Connect’s editorial team and published on Connect’s news emails. Showcase your intelligence and broaden your reach.